Description
The study identifies a novel transcription factor complex regulating IRF2BP2, but doesn’t explain what molecular signals or conditions drive these three factors to specifically associate at this locus. This knowledge gap limits understanding of when and how this oncogenic program is activated in neuroblastoma development.
Gap type: unexplained_observation Source paper: Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation. (2024, Neuro-oncology, PMID:38864832)